Management of menorrhagia in women with inherited bleeding disorders: general principles and use of desmopressin
暂无分享,去创建一个
[1] M. Blombäck,et al. On an inherited autosomal hemorrhagic diathesis with antihemophilic globulin (AHG) deficiency and prolonged bleeding time. , 2009, Acta medica Scandinavica.
[2] S. Magennis. Introduction to the Issue , 2008, Review of Environmental Economics and Policy.
[3] P. Kouides,et al. Menorrhagia associated with laboratory abnormalities of hemostasis: epidemiological, diagnostic and therapeutic aspects , 2007, Journal of thrombosis and haemostasis : JTH.
[4] A. Tosetto,et al. How to estimate bleeding risk in mild bleeding disorders , 2007, Journal of thrombosis and haemostasis : JTH.
[5] J. Ely,et al. Abnormal uterine bleeding: a management algorithm. , 2006, Journal of the American Board of Family Medicine : JABFM.
[6] C. Demers,et al. Gynaecological and obstetric management of women with inherited bleeding disorders , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[7] A. Tosetto,et al. Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter study , 2006, Journal of thrombosis and haemostasis : JTH.
[8] R. Kadir,et al. Women and von Willebrand disease: controversies in diagnosis and management. , 2006, Seminars in thrombosis and hemostasis.
[9] S. Pavord,et al. The obstetric and gynaecological management of women with inherited bleeding disorders – review with guidelines produced by a taskforce of UK Haemophilia Centre Doctors’ Organization , 2006, Haemophilia : the official journal of the World Federation of Hemophilia.
[10] A. Tosetto,et al. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM‐1 VWD) , 2006, Journal of thrombosis and haemostasis : JTH.
[11] A. Tosetto,et al. The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study , 2005, Journal of thrombosis and haemostasis : JTH.
[12] L. Amesse,et al. Oral Contraceptives and DDAVP Nasal Spray: Patterns of Use in Managing vWD-Associated Menorrhagia: A Single-Institution Study , 2005, Journal of pediatric hematology/oncology.
[13] A. James,et al. More than menorrhagia: a review of the obstetric and gynaecological manifestations of bleeding disorders , 2005, Haemophilia : the official journal of the World Federation of Hemophilia.
[14] D. Economides,et al. The use of levonorgestrel‐releasing intrauterine system for treatment of menorrhagia in women with inherited bleeding disorders , 2004, BJOG : an international journal of obstetrics and gynaecology.
[15] D. Matchar,et al. Testing for von Willebrand Disease in Women With Menorrhagia: A Systematic Review , 2004, Obstetrics and gynecology.
[16] D. Economides,et al. von Willebrand disease in women with menorrhagia: a systematic review , 2004, BJOG : an international journal of obstetrics and gynaecology.
[17] I. Scharrer. Women with von Willebrand disease , 2004, Hämostaseologie.
[18] Martin Oehler,et al. Menorrhagia: an update , 2003, Acta obstetricia et gynecologica Scandinavica.
[19] B. Evatt,et al. Medical, reproductive and psychosocial experiences of women diagnosed with von Willebrand's disease receiving care in haemophilia treatment centres: a case–control study , 2003, Haemophilia : the official journal of the World Federation of Hemophilia.
[20] D. Economides,et al. DDAVP nasal spray for treatment of menorrhagia in women with inherited bleeding disorders: a randomized placebo‐controlled crossover study , 2002, Haemophilia : the official journal of the World Federation of Hemophilia.
[21] P. Kouides,et al. Menorrhagia from a haematologist's point of view. Part I: initial evaluation , 2002, Haemophilia : the official journal of the World Federation of Hemophilia.
[22] P. Kouides,et al. Menorrhagia from a haematologist's point of view. Part II: management , 2002, Haemophilia : the official journal of the World Federation of Hemophilia.
[23] M. Blombäck,et al. Desmopressin in the treatment of menorrhagia in women with no common coagulation factor deficiency but with prolonged bleeding time , 2002, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[24] F. Rodeghiero,et al. Congenital von Willebrand disease type I: definition, phenotypes, clinical and laboratory assessment. , 2001, Best practice & research. Clinical haematology.
[25] C. Leissinger,et al. High‐dose DDAVP intranasal spray (Stimate®) for the prevention and treatment of bleeding in patients with mild haemophilia A, mild or moderate type 1 von Willebrand disease and symptomatic carriers of haemophilia A , 2001, Haemophilia : the official journal of the World Federation of Hemophilia.
[26] P. Mannucci,et al. Clinical manifestations and complications of childbirth and replacement therapy in 385 Iranian patients with type 3 von Willebrand disease , 2000, British journal of haematology.
[27] F. Howard,et al. Gynaecological and obstetrical morbidity in women with type I von Willebrand disease: results of a patient survey , 2000, Haemophilia : the official journal of the World Federation of Hemophilia.
[28] A. Hassett,et al. von Willebrand disease and bleeding in women , 1999, Haemophilia : the official journal of the World Federation of Hemophilia.
[29] M. Blombäck. Scientific visits to the Åland Islands , 1999, Haemophilia : the official journal of the World Federation of Hemophilia.
[30] Bolton‐Maggs. Bleeding problems in factor XI deficient women , 1999, Haemophilia : the official journal of the World Federation of Hemophilia.
[31] Kadir,et al. Assessment of menstrual blood loss and gynaecological problems in patients with inherited bleeding disorders , 1999, Haemophilia : the official journal of the World Federation of Hemophilia.
[32] R. Kadir,et al. Factor XI deficiency in women , 1999, American journal of hematology.
[33] C. Kessler,et al. Females with von Willebrand disease: 72 years as the silent majority , 1998, Haemophilia : the official journal of the World Federation of Hemophilia.
[34] Y. Beyth,et al. Severe juvenile vaginal bleeding due to Glanzmann's thrombasthenia: Case report and review of the literature , 1998, American journal of hematology.
[35] D. Economides,et al. Frequency of inherited bleeding disorders in women with menorrhagia , 1998, The Lancet.
[36] P. Mannucci,et al. Prospective Multicenter Study on Subcutaneous Concentrated Desmopressin for Home Treatment of Patients with von Willebrand Disease and Mild or Moderate Hemophilia A , 1996, Thrombosis and Haemostasis.
[37] F. Rodeghiero,et al. Clinical usefulness of desmopressin for prevention of surgical bleeding in patients with symptomatic heterozygous factor XI deficiency , 1996, British journal of haematology.
[38] P. Scholten,et al. A Simple Visual Assessment Technique to Discriminate Between Menorrhagia and Normal Menstrual Blood Loss , 1995, Obstetrics and gynecology.
[39] F. Rodeghiero,et al. Consistency of responses to separate desmopressin infusions in patients with storage pool disease and isolated prolonged bleeding time. , 1993, Thrombosis research.
[40] K McPherson,et al. The epidemiology of hysterectomy: Findings in a large cohort study , 1992, British journal of obstetrics and gynaecology.
[41] L. Aledort,et al. Nasal spray desmopressin (DDAVP) for mild hemophilia A and von Willebrand disease. , 1991, Annals of internal medicine.
[42] J. Higham,et al. Assessment of menstrual blood loss using a pictorial chart , 1990, British journal of obstetrics and gynaecology.
[43] S. Lethagen,et al. Intranasal desmopressin (DDAVP) by spray in mild hemophilia A and von Willebrand's disease type I , 1990, Blut.
[44] F. Rodeghiero,et al. Consistency of responses to repeated DDAVP infusions in patients with von Willebrand's disease and hemophilia A. , 1989, Blood.
[45] E. Sacchi,et al. Intravenous and Subcutaneous Administration of Desmopresssin (DDAVP) to Hemophiliacs: Pharmacokinetics and Factor VIII Responses , 1987, Thrombosis and Haemostasis.
[46] S. Lethagen,et al. Intranasal and Intravenous Administration of Desmopressin: Effect on F VIII/vWF, Pharmacokinetics and Reproducibility , 1987, Thrombosis and Haemostasis.
[47] C. Cowell,et al. Acute adolescent menorrhagia. , 1981, American journal of obstetrics and gynecology.
[48] L. Hallberg,et al. MENSTRUAL BLOOD LOSS???A POPULATION STUDY. VARIATION AT DIFFERENT AGES AND ATTEMPTS TO DEFINE NORMALITY , 1967 .
[49] V. Picozzi,et al. Bleeding disorders in premenopausal women: (another) public health crisis for hematology? , 2006, Hematology. American Society of Hematology. Education Program.
[50] O. Derman,et al. Coagulation disorders as the cause of menorrhagia in adolescents , 2004, International journal of adolescent medicine and health.
[51] Francesco Rodeghiero,et al. Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment. , 2003, Haematologica.
[52] F. Rodeghiero,et al. Consistency of responses to repeated DDAVP infusions in patients with von Willebrand's disease and hemophilia A , 1989 .
[53] J. Silwer. von Willebrand's disease in Sweden. , 1973, Acta paediatrica Scandinavica. Supplement.